financetom
Business
financetom
/
Business
/
Edwards Lifesciences Insider Sold Shares Worth $447,977, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Edwards Lifesciences Insider Sold Shares Worth $447,977, According to a Recent SEC Filing
May 26, 2025 2:21 AM

05:17 PM EDT, 05/06/2025 (MT Newswires) -- Bernard J Zovighian, Director, CEO, on May 03, 2025, sold 5,980 shares in Edwards Lifesciences ( EW ) for $447,977. Following the Form 4 filing with the SEC, Zovighian has control over a total of 61,889 shares of the company, with 58,284 common shares held directly and 3,606 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1099800/000122520825004799/xslF345X05/doc4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arhaus Shares Slip After Lower Q3 Results, 2024 Revenue Guidance Reduced
Arhaus Shares Slip After Lower Q3 Results, 2024 Revenue Guidance Reduced
Nov 7, 2024
10:32 AM EST, 11/07/2024 (MT Newswires) -- Arhaus ( ARHS ) shares slipped recent trading Thursday after the company posted lower Q3 results compared with a year ago and reduced its 2024 revenue guidance range. The home furnishings retailer reported Q3 net and comprehensive income of $0.07 per share, down from $0.14 a year earlier. Analysts polled by Capital IQ...
N-able Shares Fall After Lowing 2024 Revenue Guidance
N-able Shares Fall After Lowing 2024 Revenue Guidance
Nov 7, 2024
10:02 AM EST, 11/07/2024 (MT Newswires) -- N-able (NABL) shares fell 4% in recent Thursday trading after it lowered its full-year 2024 revenue guidance. The company reported Q3 non-GAAP earnings of $0.13 per diluted share, up from $0.09 a year earlier. Analysts polled by Capital IQ expected $0.10. Revenue for the quarter ended Sept. 30 was $116.4 million, up from...
Phathom Pharmaceuticals Shares Fall After Q3 Loss Widens
Phathom Pharmaceuticals Shares Fall After Q3 Loss Widens
Nov 7, 2024
10:34 AM EST, 11/07/2024 (MT Newswires) -- Phathom Pharmaceuticals' ( PHAT ) shares were down 3.3% in recent Thursday trading after the company reported a Q3 net loss of $1.05 per diluted share, wider than a loss of $0.54 a year earlier. Two analysts polled by Capital IQ projected a loss of $1.47 per share. Net revenue for the quarter...
PharmAla Up 10% On Supply Contract
PharmAla Up 10% On Supply Contract
Nov 7, 2024
10:38 AM EST, 11/07/2024 (MT Newswires) -- PharmAla Biotech Holdings ( MDXXF ) was up more than 19% in morning trade Thursday after saying has been contracted as a supplier of MDMA to a clinical trial at Yale University. Requests for clinical trial material - LaNeo MDMA - for research purposes continues to occupy the company at this time, said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved